Changing The Debate About Health Research For Development

Abrahams, Naeemah; Adhikari, Ramesh; Bhagwat, I.P.; Christofides, Nicola; Djibuti, Mamuka; Dyalchand, Ashok; Gotsadze, George; Grzmava, O; Huertas, L L R; Jacobs, Troy; Jewkes, Rachel; Kapadia-Kundu, Nandita; Karnikowski, M G O; Kimboka, Sabas; Kitua, AY; Lens, J U; Lopez, Alvaro; Lugina, Helen; Malecela-Lazaro,; Mashalla, Yohana; Mishra, Ashok K.; Mishra, Suyash; Mlay, R; Moreno, Mark; Mpanda, S; Mwanga, Feddy; Ndossi, Godwin; Nigenda, Gustavo; Nkwera, A; Nóbrega, Otávio de Tolêdo; Pahari, Sandip; Paz, S A; Phoolchareon, W; Ramachandran, Prema; Rannan-Eliya, Ravindra P; Rodrigues, K G; Salazar, A.; Sarma, P. Sankara; Shija, J; Silver, Lynn; Tatsanavivat, Pyatat; Kr, Thankappan; Tuesta, A J A; Vasadze, Otar; Vélez, Alfredo Casta; Webster, Noah; Yesudian, C. A. K.

doi:10.1057/palgrave.jphp.3190028

Cited by 6 publications

(3 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, voluntary differential pricing of essential pharmaceuticals for middle-and low-income countries does not appear to be occurring in Brazil. The high ratio between privateretail and international-bulk price data suggests that the public-interest procurement and distribution systems called for by the Brazil's Health Policy, although only partially implemented (24), may offer the most cost-effective method for guaranteeing access to essential drugs. All in all, the relatively simple method described in this work may be useful for drawing comparison between countries and arriving at some international standard.…”

Section: Discussionmentioning

confidence: 99%

Retail prices of essential drugs in Brazil: an international comparison

Nóbrega¹,

Marques²,

Araújo³

et al. 2007

Rev Panam Salud Publica

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Retail prices of essential drugs in Brazil: an international comparison

Nóbrega¹,

Marques²,

Araújo³

et al. 2007

Rev Panam Salud Publica

View full text Add to dashboard Cite

show abstract

“…Differences in the institutional and historical contexts imply that reforms undertaken may not necessarily reflect the same factors and problems. For the success of a care reform, its preparation with a compliance of national guidelines needs to be guaranteed and participation of the society needs to be encouraged [ 23 ].…”

Section: Theoretical Backgroundmentioning

confidence: 99%

Integration of care systems in Portugal: anatomy of recent reforms

Szczygieł¹,

Redondo²

2014

Int J Integr Care

View full text Add to dashboard Cite

Background: Integrated care is increasingly present in the agenda of policy-makers, health professionals and researchers as a way to improve care services in relation to access, quality, user satisfaction and efficiency. These are overarching objectives of most sectoral reforms. However, health care and social care services and systems are more and more dependent on the performance of each other, imposing the logic of network. Demographic, epidemiologic and cultural changes result in pressure to increase efficiency and efficacy of services and organisations in both sectors and that is why integrated care has become so relevant in the last years.

show abstract

“…Internationally in health services research PPI is widely recognized as being essential to the development of quality health services that are fit for purpose (Minogue and Girdlestone, 2010). Compared to health service delivery, PPI in health research management is globally a more recent movement and set of practices (Abrahams et al, 2004;Elberse et al, 2012;Gagnon et al, 2014;NIHR, 2015;PCORI, 2018).…”

Section: Introductionmentioning

confidence: 99%

Is Co-production Just a Pipe Dream for Applied Health Research Commissioning? An Exploratory Literature Review

Tembo

Morrow²,

Worswick

et al. 2019

Front. Sociol.

View full text Add to dashboard Cite

Background and Rationale: Internationally, the idea of "co-production' has become more popular in health research because of the promise of partnership between researchers and patients to create research that focuses on patients' needs. Patient and public involvement (PPI) at an early stage in deciding what research should be funded, can improve the quality and impact of research. However, professional power over the process places limits on the public practising their participatory rights for involvement in commissioning research that affects them and can leave members of the public feeling unheard or excluded, particularly within the context of early phase applied health research. Aim: This article explores whether and how the public can be involved in the co-production of research commissioning early on in the process, with a focus on the power relations that pervade basic and early phase translational applied health research. Methods: An exploratory literature review of international peer-reviewed and gray health research literature using structured searches of electronic databases and key search terms. Results: There is very little literature that critically evaluates how PPI is embedded into the early phases of the commissioning process. The field of basic or early translational applied research appear to be particularly challenging. Four themes which emerged from the review are: reasons for PPI in research commissioning; benefits of PPI at strategic levels of research commissioning; contributions of patients and members of the public; improving PPI in research commissioning. Conclusion: Although the public are being consulted at some stages of the research commissioning process, it is evident that the process of determining research priorities and agendas is far from being widely co-produced. Moving PPI from a consultative paternalistic model to a collaborative partnership model should be a priority for commissioners. Significant changes to communication, practices, systems, structures, or cultures that exclude patients and the public from contributing in meaningful ways, are needed to fulfill the potential of co-produced models of research commissioning.

show abstract

Changing The Debate About Health Research For Development

Cited by 6 publications

References 3 publications

Retail prices of essential drugs in Brazil: an international comparison

Retail prices of essential drugs in Brazil: an international comparison

Integration of care systems in Portugal: anatomy of recent reforms

Is Co-production Just a Pipe Dream for Applied Health Research Commissioning? An Exploratory Literature Review

Contact Info

Product

Resources

About